US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 13, 2015 (11 years ago)

Fluoxetine Capsules USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.

What was recalled

Fluoxetine Capsules USP, 10 mg, in 100-count bottles, Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland, Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960. NDC 50111-647-01

Recalling firm
Teva Pharmaceuticals USA
NDC code
50111-647-01
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0970-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Fluoxetine recalls

See all
Class II · Moderate risk Completed

Fluoxetine Tablets

Reason CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

Torrent Pharma Inc. D-0456-2025
Class II · Moderate risk Completed

Fluoxetine Tablets

Reason CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

Torrent Pharma Inc. D-0455-2025
Class III · Low risk Terminated

Fluoxetine Tablets USP

Reason Failed impurities/ degradation specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling all lots within expiry due to out of specification (OOS) test result for the lactoside impurity obtained during routine stability testing activities.

Teva Pharmaceuticals USA NDC 0093-7188-56 D-0578-2018
Class II · Moderate risk Terminated

Fluoxetine Capsules USP

Reason Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.

Teva Pharmaceuticals USA NDC 50111-648-02 D-0971-2015
Class III · Low risk Terminated

Fluoxetine Capsules USP

Reason Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.

Sandoz Incorporated NDC 0781-2822-01 D-0291-2015